Search - tctmd.com

Displaying 241 - 260 of 552

Sort: Relevancy | Date

News Conference News EAS 2021

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Michael O'Riordan

June 07, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Conference News ACC 2021

New STRENGTH Analysis Revives Omega-3 Debate

Todd Neale

May 20, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Daily News

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Todd Neale

May 14, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

Experts Fear Coronary CT Advice for Patients Misses the Mark

Michael O'Riordan

March 19, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

Prostate Cancer Treatment Heightens Arrhythmia Risk

Todd Neale

February 23, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Daily News

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

Michael O'Riordan

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

Advertisement

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

New STRENGTH Analysis Revives Omega-3 Debate

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

May 2021 News Roundup

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

April 2021 News Roundup

Roughly 80% of ESC Guideline Writers Have Financial COIs

Experts Fear Coronary CT Advice for Patients Misses the Mark

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Prostate Cancer Treatment Heightens Arrhythmia Risk

FDA Approves Evinacumab for Rare Homozygous FH

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content